Research Focus
The research aims to conceptualize targeted therapy for Oral Squamous Cell Carcinoma (OSCC) and provides insights into both prognostic and theranostic aspects.
Preclinical and clinical research on the tumor microenvironment stroma and the PI3K/Akt/mTOR pathway in OSCC within the Indian population, particularly the South Indian population, remains limited.
Thus, the present study seeks to broaden the scope of OSCC management and tailor these inhibitors for targeted therapy specific to OSCC patients.